Kj. Witcher et al., MODULATION OF IMMUNE CELL-PROLIFERATION BY GLYCEROL MONOLAURATE, Clinical and diagnostic laboratory immunology, 3(1), 1996, pp. 10-13
Previous studies have shown that glycerol monolaurate (GML), a surfact
ant commonly used in a wide variety of food and cosmetic products, inh
ibits the production of a variety of exotoxins by group A streptococci
and staphylococci. Given the highly lipophilic nature of the structur
e of GML, it is suspected that the surfactant exerts its toxin inhibit
ion effects via interaction with the cell membrane. The present study
attempted to characterize some of the potential targets of GML action
using the model system of lymphocyte activation. Results from murine s
plenocytes show that GML stimulates proliferation at concentrations be
tween 10(-5) and 5 mu g/ml/5 x 10(5) splenocytes. At concentrations gr
eater than 5 mu g/ml, GML inhibited lymphocyte proliferation and block
ed the proliferative effects of the lymphocyte mitogens phorbol myrist
ate acetate and concanavalin A and the potent T-cell mitogen toxic sho
ck syndrome toxin-l, Studies using purified immune cell subsets indica
ted that GML at a concentration of 0.1 mu g/ml optimally induced proli
feration of T cells but did not affect B cells, At higher concentratio
ns, CML inhibited the toxic shock syndrome toxin-1 mitogenic effects o
n T cells, but did not inhibit the lipopolysaccharide-induced stimulat
ion of B cells, suggesting that CML preferentially affects the T-cell
population. GML-induced proliferation was blocked by the immunosuppres
sive drug cyclosporin A, suggesting that GML may be exerting its T-cel
l-proliferative effects along the calcium-dependent inositol phospholi
pid signal transduction pathway.